Feature Channels

Pharmaceuticals

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

Curb Overuse of Antibiotics to Reduce Drug-Resistant Superbug

View | Comment

An aggressive campaign to reduce the unnecessary use of antibiotics has helped cut the rate of infection with a dangerous drug-resistant bacteria at The Valley Hospital in Ridgewood, NJ, by nearly 40 percent.

Medicine

Channels:

Keywords:

New Nanogel for Drug Delivery

View | Comment

MIT chemical engineers have designed a new type of self-healing hydrogel that could be injected through a syringe. Such gels, which can carry one or two drugs at a time, could be useful for treating cancer, macular degeneration, or heart disease, among other diseases, the researchers say.

Science

Channels:

Keywords:

Study Could Pave the Way for Painkillers with Fewer Side Effects

View | Comment

delta-opioid-receptor-bound-peptidecopy.jpg

Researchers have long sought alternatives to morphine – a powerful and widely used painkiller – that curb its side effects, including dependency, nausea and dizziness. Now, an experiment at the Department of Energy’s SLAC National Accelerator Laboratory has supplied the most complete atomic-scale map of such a compound docked with a cellular receptor that regulates the body’s pain response and tolerance.

Science

Channels:

Keywords:

The Science Behind Commonly Used Anti-Depressants Appears to Be Backwards, Researchers Say

View | Comment

The science behind many anti-depressant medications appears to be backwards, say the authors of a paper that challenges the prevailing ideas about the nature of depression and some of the world’s most commonly prescribed medications.

Science

Channels:

Structure-Based Design Used as Tool for Engineering Deimmunized Biotherapeutics

View | Comment

While methods for identifying immunogenic hotspots, or epitopes, are evolving rapidly, technologies to redesign the hotspots while maintaining biotherapeutic activity and stability are far less developed.

Medicine

Channels:

Study Identifies Promising Drug Target in Certain Breast and Ovarian Cancers

View | Comment

Study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug olaparib is potentially much wider – and offers a ready means of identifying them.

Science

Channels:

Keywords:

Drug Detectives

View | Comment

12-BPS-Andersen-Toxicity-Cornell-gramicidin.png

Good drugs are hard to design: they must not only effectively treat a medical condition, but they must also do so without having side effects that outweigh their benefits. Sometimes, toxic side effects aren’t discovered until late in development, when substantial time and money have already been invested. Now, researchers have devised a new drug screen that capitalizes on the tendency of toxic compounds to alter the properties of the lipid bilayer that encases cells.

Medicine

Channels:

Keywords:

Health Care Groups Identify Potential Measures to Address Ongoing Drug Shortages

View | Comment

A report from a summit organized last year by the American Hospital Association (AHA), the American Society of Anesthesiologists,® the American Society of Clinical Oncology, the American Society of Health-System Pharmacists, the Institute for Safe Medication Practices, and The Pew Charitable Trusts summarizes manufacturing, regulatory, and economic issues related to drug shortages, as well as potential solutions.

Medicine

Channels:

FDA Approves New Drug that has Shown Groundbreaking Results in Patients with Estrogen-Receptor Positive Advanced Breast Cancer

View | Comment

NIK_2504.jpg

FDA has approved IBRANCE (palbociclib), representing a new treatment method to arrest tumor growth in certain advanced breast cancer patients. IBRANCE targets a key family of proteins responsible for cell growth. Results of a phase 2 study found the combination of IBRANCE and letrozole improved progression-free survival by 10 months as compared to letrozole alone. Over 80 percent of metastatic ER+ breast cancer patients received some benefit from this treatment.

Medicine

Channels:

Keywords:

Study Shows the Top Ten Global Health Pharmaceutical Supply Chain Issues

View | Comment

Global pharmaceutical supply chains are fragmented and lack coordination, facing at least 10 key challenges, according to the researchers. Their study sheds light on areas of weakness and what specifically is needed to strengthen the global health pharmaceutical supply chains.